Synthesis and structure–activity relationship of 3,4′-bispyridinylethylenes: Discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer

Bioorganic & Medicinal Chemistry Letters
2006.0

Abstract

Structure-based design and synthesis of the 3,4'-bispyridinylethylene series led to the discovery of 3-isoquinolinylpyridine 13a as a potent PKB/Akt inhibitor with an IC(50) of 1.3nM against Akt1. Compound 13a shows excellent selectivity against distinct families of kinases such as tyrosine kinases and CAMK, and displays poor to marginal selectivity against closely related kinases in the AGC and CMGC families. Moreover, 13a demonstrates potent cellular activity comparable to staurosporine, with IC(50) values of 0.42 and 0.59microM against MiaPaCa-2 and the Akt1 overexpressing FL5.12-Akt1, respectively. Inhibition of phosphorylation of the Akt downstream target GSK3 was also observed in FL5.12-Akt1 cells with an EC(50) of 1.5microM. The X-ray structures of 12 and 13a in complex with PKA in the ATP-binding site were determined.

DOI： 10.1016/j.bmcl.2005.12.065

Knowledge Graph

Similar Paper

Synthesis and structure–activity relationship of 3,4′-bispyridinylethylenes: Discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer
Bioorganic & Medicinal Chemistry Letters 2006.0
Discovery of trans-3,4′-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation
Bioorganic & Medicinal Chemistry Letters 2006.0
Discovery and SAR of oxindole–pyridine-based protein kinase B/Akt inhibitors for treating cancers
Bioorganic & Medicinal Chemistry Letters 2006.0
Identification of a novel 3,5-disubstituted pyridine as a potent, selective, and orally active inhibitor of Akt1 kinase
Bioorganic & Medicinal Chemistry Letters 2006.0
Design, Synthesis, and Biological Evaluation of Substituted Pyrimidines as Potential Phosphatidylinositol 3-Kinase (PI3K) Inhibitors
Journal of Medicinal Chemistry 2016.0
Discovery of a novel protein kinase B inhibitor by structure-based virtual screening
Bioorganic & Medicinal Chemistry Letters 2009.0
Syntheses of Potent, Selective, and Orally Bioavailable Indazole-Pyridine Series of Protein Kinase B/Akt Inhibitors with Reduced Hypotension
Journal of Medicinal Chemistry 2007.0
Synthetic sulfoglycolipids targeting the serine–threonine protein kinase Akt
Bioorganic & Medicinal Chemistry 2016.0
Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies
Bioorganic & Medicinal Chemistry Letters 2006.0
Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors
Bioorganic & Medicinal Chemistry 2012.0